Descovy is a brand-name oral tablet that’s prescribed to treat HIV and lower the risk of contracting HIV. Descovy contains two active ingredients: emtricitabine and tenofovir alafenamide.

Descovy is approved by the Food and Drug Administration (FDA) to:

  • Treat HIV: Descovy is FDA-approved for use in combination with other HIV medications to treat HIV in adults and in children who weigh at least 35 kilograms (kg), which is about 77 pounds (lb). Descovy may also be used in children weighing at least 14 kg (about 31 lb) to less than 35 kg. In this second group of children, Descovy is used in combination with certain other HIV medications. (These other drugs cannot be protease inhibitors that require use with other drugs.)
  • Reduce the risk of HIV: Descovy is also used to reduce the risk of contracting HIV. This use is called pre-exposure prophylaxis (PrEP). “Prophylaxis” means to prevent the spread of a condition. PrEP is for people who don’t have HIV but are at risk for contracting the virus. It’s used for this purpose in adults and adolescents* who weigh at least 35 kg. However, Descovy is not approved for PrEP in females† who are at risk for contracting HIV through vaginal intercourse.

* Adolescents describes children ages 12 years and older.
Sex and gender exist on spectrums. Use of the term “female” in this article refers to sex assigned at birth.

Drug details

You’ll find key information about Descovy below.

The Food and Drug Administration (FDA) approves prescription drugs such as Descovy to treat or prevent certain conditions.

Descovy is FDA-approved for use as HIV pre-exposure prophylaxis (PrEP). PrEP treatment is when a person uses HIV medication before they might come into contact with HIV. This helps prevent them from contracting HIV.

Descovy is approved as HIV PrEP for adults and adolescents* who weigh at least 35 kilograms (kg), which is about 77 pounds (lb). It’s used for this purpose in people who are at risk for contracting HIV but who don’t already have the virus.

Before starting Descovy for PrEP, your doctor will test you for HIV. They must confirm that you’re HIV-negative before starting Descovy for PrEP.

Descovy is not approved for use as HIV PrEP in females† who are at risk for contracting HIV through vaginal intercourse.

For more information about this condition, see our HIV and AIDS hub. And to learn more about Descovy for PrEP, refer to this in-depth article.

Note: See the “Descovy for HIV” section below to learn more about Descovy’s other approved use.

* Adolescents describes children ages 12 years and older.
Sex and gender exist on spectrums. Use of the term “female” in this article refers to sex assigned at birth.

Who’s at risk for contracting HIV?

People at risk for contracting HIV include those who:

Children and Descovy for PrEP

Descovy is FDA-approved for HIV PrEP in adolescents* who weigh at least 35 kilograms (kg), which is about 77 pounds (lb) and are at risk for HIV.

Clinical studies of Descovy used for HIV PrEP in adults were used for FDA approval of adolescent use.

* Adolescents describes children ages 12 years and older.

In addition to its use for PrEP, Descovy is also approved by the Food and Drug Administration (FDA) to treat HIV in adults and in children who weigh at least 35 kilograms (kg), which is about 77 pounds (lb).

Descovy may also be used in children weighing at least 14 kg (about 31 lb) to less than 35 kg. However, it’s only used for this weight range when taken with certain other HIV medications. These include medications other than protease inhibitors (a type of HIV medication) that require use with certain other drugs.

Descovy is used in combination with other HIV medications to treat HIV.

About HIV

HIV is a virus that’s transmitted through blood and other bodily fluids. Once a person has contracted HIV, the virus will attack certain cells in their immune system. (The immune system helps the body fight off infection and disease.)

If HIV is not treated, it reduces the immune system’s ability to fight infection. Eventually, untreated HIV puts the person who has it at risk for potentially fatal diseases. This is typically when a person is diagnosed with stage 3 HIV, the most severe stage of HIV.

For more information about this condition, see our HIV and AIDS hub.

Note: See the “Descovy for PrEP” section above to learn about Descovy’s use as pre-exposure prophylaxis.

Children and Descovy for HIV

Descovy is used to treat HIV in children weighing 35 kilograms (kg), which is about 77 pounds (lb), or more. It’s used in combination with other HIV drugs for this purpose.

Descovy is also used to treat HIV in children who weigh at least 14 kg (about 31 lb) to less than 35 kg. However, it’s only used for this weight range when taken with certain other HIV medications. These include medications other than protease inhibitors (a type of HIV medication) that require use with certain other drugs.

Examples of such drugs that shouldn’t be used for this age range (in combination with Descovy) include:

  • atazanavir/cobicistat (Evotaz)
  • darunavir/cobicistat (Prezcobix)

Descovy can cause mild or serious side effects. The following lists contain some of the key side effects that may occur while taking Descovy. These lists do not include all possible side effects.

For more information on the possible side effects of Descovy, talk with your doctor or pharmacist. They can give you tips on how to deal with any side effects that may be bothersome.

Note: The Food and Drug Administration (FDA) tracks side effects of drugs they have approved. If you would like to report to the FDA a side effect you’ve had with Descovy, you can do so through MedWatch.

More common side effects

The more common side effects of Descovy can include:

  • headache
  • fatigue
  • abdominal pain
  • nausea*
  • diarrhea*

Most of these side effects may go away within a few days or a couple of weeks. If they’re more severe or don’t go away, talk with your doctor or pharmacist.

* For more information, see “Side effect details” below.

Serious side effects

Serious side effects from Descovy aren’t common, but they can occur. Call your doctor right away if you have serious side effects. Call 911 if your symptoms feel life threatening or if you think you’re having a medical emergency.

Serious side effects and their symptoms can include:

  • Immune reconstitution syndrome (when your immune system strengthens and reduces HIV infection symptoms, but then responds to other infections you may have had and causes unexpected infection symptoms). These symptoms can include:
  • New or worsening kidney damage. Symptoms can include:
    • urinating less often than usual
    • fatigue
    • weakness
    • nausea
    • vomiting
  • Liver damage. Symptoms can include:
    • nausea
    • loss of appetite
    • vomiting
    • jaundice
    • abdominal pain
    • dark-colored urine
  • Lactic acidosis (buildup of lactic acid in your body). Symptoms can include:
    • fruity-smelling breath
    • muscle pain
    • nausea
    • vomiting
    • hands or feet that feel cold and look blue
    • dizziness
    • trouble breathing
    • fatigue
    • rapid or unusual heartbeat
  • Loss of bone density, which can lead to osteoporosis. Symptoms can include bone fractures or breaks that happen more easily than usual.
  • Risk of worsening of hepatitis B.*
  • Risk of resistance to Descovy treatment.*
  • Allergic reactions.†

* Descovy has a boxed warning from the Food and Drug Administration (FDA) for this risk. A boxed warning is the most serious warning the FDA requires. It alerts doctors and patients about drug effects that may be dangerous. To learn more, see “FDA warnings” at the beginning of this article.
† For more information, see “Side effect details” below.

Side effects in children

In clinical studies of Descovy in children, the side effects were similar to those seen in adults.

However, in one group of children ages 6 to 12 years old, there was a decrease in CD4 cell counts. CD4 cells are immune system cells that HIV attacks. As HIV makes more copies of itself in your body, the number of healthy CD4 cells goes down. The CD4 cell count is one way that doctors monitor your body’s response to medication. Higher CD4 counts indicate better immune system health and greater ability to fight off infection.

In one clinical study, the children received Descovy after HIV had already been suppressed in their bodies. (Suppression means the virus was at very low or undetectable levels.) After 48 weeks of Descovy treatment, the children’s CD4 cell counts were decreased by a small amount. This decrease in CD4 cell counts wasn’t seen in children ages 12 to 18 years old who were new to HIV treatment.

Your child’s doctor will monitor their CD4 cell counts before and during treatment with Descovy. They will recommend the best treatment option to keep your child’s immune system healthy.

Side effect details

You may wonder how often certain side effects occur with this drug, or whether certain side effects pertain to it. Here’s some detail on some of the side effects this drug may or may not cause. For more details about side effects of Descovy, see this article.

Allergic reaction

As with most drugs, some people can have an allergic reaction after taking Descovy. Symptoms of a mild allergic reaction can include:

A more severe allergic reaction is rare but possible. Symptoms of a severe allergic reaction can include:

  • swelling under your skin, typically in your eyelids, lips, hands, or feet
  • swelling of your tongue, mouth, or throat
  • trouble breathing

It’s unknown how many people have had an allergic reaction to Descovy.

Call your doctor right away if you have a severe allergic reaction to Descovy. Call 911 if your symptoms feel life threatening or if you think you’re having a medical emergency.

Diarrhea

Diarrhea may happen while you’re taking Descovy.

Diarrhea is the most common side effect of Descovy when it’s used for HIV pre-exposure prophylaxis (PrEP).

Diarrhea wasn’t reported as a side effect of Descovy for people taking the drug to treat HIV. However, diarrhea may be an early symptom of HIV. Other early symptoms of HIV may also include fever, headache, and muscle pain.

If you have diarrhea while taking Descovy, talk with your doctor about ways to manage this side effect. They can also determine if the diarrhea is a symptom of HIV.

Nausea

Descovy may cause nausea in some people. In clinical studies, nausea is the most common side effect of Descovy when it’s used to treat HIV.

Nausea may also be a symptom of more serious side effects, including lactic acidosis and liver damage. See the “Serious side effects” section for more details on these side effects.

If you have nausea while taking Descovy, talk with your doctor. They can determine the cause of the nausea and recommend ways to manage it.

Weight gain (not a side effect)

The manufacturer of Descovy has not reported weight gain as a side effect of the drug. It’s not clear if Descovy is associated with weight gain or not.

In a clinical study, weight gain occurred when tenofovir alafenamide (one of the active ingredients in Descovy) was used with other HIV drugs. However, it’s not clear if the weight gain was caused by tenofovir alafenamide or the other drugs it was taken with.

Talk with your doctor if you’re concerned about weight gain during your HIV treatment.

When Descovy is used to treat HIV, it’s taken in combination with other drugs. It’s never used on its own for this purpose.

Examples of other drugs that Descovy is used with include:

  • dolutegravir (Tivicay)
  • raltegravir (Isentress)
  • darunavir/cobicistat (Prezcobix)
  • darunavir (Prezista)
  • atazanavir (Reyataz)
  • atazanavir/cobicistat (Evotaz)
  • doravirine (Pifeltro)
  • efavirenz (Sustiva)
  • rilpivirine (Edurant)

Descovy is taken on its own when used as HIV pre-exposure prophylaxis (PrEP).

The following information describes dosages that are commonly used or recommended. However, be sure to take the dosage your doctor prescribes for you. Your doctor will determine the best dosage to fit your needs.

If you’d like to learn more about dosages of Descovy, visit this article.

Drug forms and strengths

Descovy comes as a tablet that’s taken by mouth. It’s available in two strengths:

  • 200 milligrams (mg) of emtricitabine/25 mg of tenofovir alafenamide
  • 120 milligrams (mg) of emtricitabine/15 mg of tenofovir alafenamide

Dosage for HIV

The usual recommended dosage for HIV treatment is one 200-mg emtricitabine/25-mg tenofovir alafenamide tablet taken once a day. This is for adults and children who weigh at least 35 kilograms (kg), which is about 77 pounds (lb).

Descovy must be used in combination with other HIV medications for this purpose.

Dosage for PrEP

The usual recommended dosage for pre-exposure prophylaxis (PrEP) is 200-mg emtricitabine/25-mg tenofovir alafenamide tablet taken once a day. This is for adults and adolescents* who weigh at least 35 kg (about 77 lb).

Descovy is used on its own for this purpose.

* Adolescents describes children ages 12 years and older.

Pediatric dosage

The usual recommended dosage for HIV treatment in children varies with body weight.

For children weighing:

  • 14 kg to less than 25 kg (about 31 lb to less than 55 lb), their dosage is one 120-mg emtricitabine/15-mg tenofovir alafenamide tablet taken once per day.
  • 25 kg to less than 35 kg (about 55 lb to 77 lb), their dosage is one 200-mg emtricitabine/25-mg tenofovir alafenamide tablet taken once per day.

In both instances, other drugs taken in combination with Descovy cannot be protease inhibitors that require use with other drugs.

For dosage recommendations for children weighing 35 kg (about 77 lb) or more, see “Dosage for HIV” above.

What if I miss a dose?

If you miss a dose of Descovy, take it as soon as you remember. However, it’s important that you don’t miss doses of Descovy.

Descovy’s effectiveness to treat or prevent HIV depends on taking the drug regularly and not missing any doses.

If you’re taking Descovy to treat HIV, missing doses can cause the virus to become resistant to the drug. Resistance means the virus is less sensitive or doesn’t respond to the drug. This can lead to the drug becoming less effective or not effective for you.

If you’re taking Descovy to prevent HIV (as PrEP), missing doses raises your risk for contracting HIV.

To help make sure you don’t miss a dose, try setting a reminder on your phone. A medication timer may be useful, too.

Will I need to use this drug long term?

Descovy is meant to be used as a long-term treatment. If you and your doctor determine that Descovy is safe and effective for you, you’ll likely take it long term.

Other drugs are available that can treat or prevent HIV. Some may be a better fit for you than others. If you’re interested in finding an alternative to Descovy, talk with your doctor. They can tell you about other medications that may work well for you.

Alternatives to treat HIV

Other medications that can be used to treat HIV include:

  • bictegravir/tenofovir alafenamide/emtricitabine (Biktarvy)
  • cabotegravir/rilpivirine (Cabenuva)
  • dolutegravir/abacavir/lamivudine (Triumeq)
  • dolutegravir/rilpivirine (Juluca)
  • dolutegravir (Tivicay)
  • tenofovir disoproxil fumarate/emtricitabine (Truvada)
  • raltegravir (Isentress)
  • elvitegravir/tenofovir alafenamide/emtricitabine/cobicistat (Genvoya)
  • elvitegravir/tenofovir disoproxil fumarate/emtricitabine/cobicistat (Stribild)
  • darunavir/tenofovir alafenamide/emtricitabine/cobicistat (Symtuza)
  • atazanavir/cobicistat (Evotaz)
  • abacavir/lamivudine (Epzicom)
  • efavirenz/lamivudine/tenofovir disoproxil fumarate (Symfi)

There are many other combinations of drugs available that can be used to treat HIV. You can find a list of all available HIV medications at the Department of Health and Human Services’ website.

Alternative for HIV PrEP

The only other medication that’s approved by the Food and Drug Administration to be used as HIV pre-exposure prophylaxis (PrEP) is tenofovir disoproxil fumarate/emtricitabine (Truvada).

You may wonder how Descovy compares to other medications that are prescribed for similar uses. Here we look at how Descovy and Truvada are alike and different. For an in-depth comparison these drugs, see this article.

Ingredients

Descovy contains the active drugs emtricitabine and tenofovir alafenamide. Truvada contains emtricitabine and tenofovir disoproxil fumarate.

Although both drugs contain emtricitabine, they contain different forms of tenofovir.

Uses

Descovy and Truvada are both used to treat HIV. Descovy is used for this purpose in adults and in children who weigh at least 14 kilograms (kg), which is about 31 lb, to less than 35 kg, which is about 77 pounds (lb). Truvada is used for this purpose in adults and in children who weigh at least 17 kg (about 37 lb).

Descovy and Truvada are both used along with other HIV medications when used to treat HIV. (In children weighing at least 14 kg to less than 35 kg, Descovy is used in combination with certain other HIV medications.)

Descovy and Truvada are also both used to reduce the risk of contracting HIV. This use is called pre-exposure prophylaxis (PrEP). Descovy and Truvada are used as HIV PrEP in people who are at risk for contracting HIV. Both drugs can be used in adults and adolescents who weigh at least 35 kg.

Descovy is not meant to be used for HIV PrEP in females* who are at risk for contracting HIV through vaginal intercourse. Truvada can be used for HIV PrEP in people at risk of contracting HIV this way, however.

* Sex and gender exist on spectrums. Use of the term “female” in this article refers to sex assigned at birth.

Drug forms and administration

Descovy comes as a tablet that you take by mouth once per day. It can be taken with or without food.

Truvada also comes as a tablet that you take by mouth. It’s typically taken once per day, with or without food.

Side effects and risks

Descovy and Truvada have some similar side effects and others that differ. Below are examples of these side effects.

More common side effects

These lists contain examples of more common side effects that can occur with Truvada or with both drugs (when taken individually). Side effects may differ based on whether you’re using the drugs to treat or prevent HIV.

Serious side effects

This list contains examples of serious side effects that can occur with both Descovy and Truvada (when taken individually).

  • severe allergic reactions
  • immune reconstitution syndrome (when your immune system strengthens and reduces HIV infection symptoms, but then responds to other infections you may have had and causes unexpected infection symptoms)
  • new or worsening kidney damage
  • liver damage
  • lactic acidosis (buildup of lactic acid in your body)
  • loss of bone density, which can lead to osteoporosis
  • risk of worsening of hepatitis B*
  • risk of resistance to Descovy or Truvada treatment*

* Descovy and Truvada have a boxed warning from the Food and Drug Administration (FDA) for this risk. A boxed warning is the most serious warning the FDA requires. It alerts doctors and patients about drug effects that may be dangerous. To learn more about this warning for Descovy, see “FDA warnings” at the beginning of this article.

Costs

Descovy and Truvada are both brand-name drugs. There is currently no generic form of Descovy. However, there is a generic form of Truvada. Brand-name medications usually cost more than generics.

The actual price you’ll pay for either drug depends on your insurance plan, your location, and the pharmacy you use. Visit Optum Perks to find coupons and savings for Descovy and Truvada.

Descovy and Biktarvy are prescribed for similar uses. Below are details of how these medications are alike and different.

Ingredients

Descovy contains two active drugs: emtricitabine and tenofovir alafenamide.

Biktarvy contains three active drugs: emtricitabine, tenofovir alafenamide, and bictegravir.

Uses

Descovy is used to treat HIV in adults and in children who weigh at least at least 35 kilograms (kg), which is about 77 pounds (lb). Descovy may also be used in children weighing at least 14 kg (about 31 lb) to less than 35 kg. It’s used for these children in combination with certain other HIV medications, excluding protease inhibitors that require use with other drugs.

Descovy is used in combination with other HIV medications to treat HIV.

Descovy is also used on its own as HIV pre-exposure prophylaxis (PrEP) in adults and adolescents* who are at risk for contracting HIV. It’s used for this purpose in people weighing 35 kg or more.

Descovy is not used as HIV PrEP in females† who are at risk for contracting HIV through vaginal intercourse.

Biktarvy is used to treat HIV in adults and in children weighing at least 14 kg. It’s used for this purpose in people who are new to HIV treatment.

Biktarvy is also used to treat HIV in people who have each of the following:

  • HIV levels of less than 50 copies/mL
  • stable history of treatment
  • no treatment failures (situation in which the drug did not work for them)
  • no genetic changes that cause their HIV to be resistant (insensitive) to the active drugs in Biktarvy

Biktarvy is considered a complete treatment regimen. It doesn’t need to be taken with other HIV medications.

* Adolescents describes children ages 12 years and older.
Sex and gender exist on spectrums. Use of the term “female” in this article refers to sex assigned at birth.

Drug forms and administration

Descovy and Biktarvy both come as tablets that you take by mouth once a day. They can both be taken with or without food.

Side effects and risks

Descovy and Biktarvy both contain emtricitabine and tenofovir alafenamide. Therefore, these medications can cause similar side effects. Below are examples of these side effects.

More common side effects

These lists contain examples of more common side effects that can occur with Biktarvy or with both drugs (when taken individually).

  • Can occur with Descovy:
    • no unique common side effects
  • Can occur with Biktarvy:
  • Can occur with both Descovy and Biktarvy:

Serious side effects

These lists contain examples of serious side effects that can occur with Descovy or with both drugs (when taken individually).

  • Can occur with Descovy:
    • loss of bone density, which can lead to osteoporosis
    • risk of resistance to Descovy treatment*
  • Can occur with Biktarvy:
    • no unique serious side effects
  • Can occur with both Descovy and Biktarvy:
    • immune reconstitution syndrome (when your immune system strengthens and reduces HIV infection symptoms, but then responds to other infections you may have had and causes unexpected infection symptoms)
    • new or worsening kidney damage
    • liver damage
    • lactic acidosis (buildup of lactic acid in your body)
    • severe allergic reactions
    • risk of worsening of hepatitis B

* Descovy has a boxed warning from the Food and Drug Administration (FDA) for this risk. A boxed warning is the most serious warning the FDA requires. It alerts doctors and patients about drug effects that may be dangerous. To learn more about this warning for Descovy, see “FDA warnings” at the beginning of this article.
† Descovy and Biktarvy have a boxed warning from the FDA for this risk. To learn more about this warning for Descovy, see “FDA warnings” at the beginning of this article.

Costs

Descovy and Biktarvy are both brand-name drugs. There are currently no generic forms of either drug. Brand-name medications usually cost more than generics.

The actual price you’ll pay for either drug depends on your insurance plan, your location, and the pharmacy you use. Visit Optum Perks to find coupons and savings for Descovy and Biktarvy.

As with all medications, the cost of Descovy can vary. The actual price you’ll pay depends on your insurance plan, your location, and the pharmacy you use.

Your insurance plan may require you to get prior authorization before approving coverage for Descovy. This means that your doctor and insurance company will need to communicate about your prescription before the insurance company will cover the drug. The insurance company will review the request and let you and your doctor know if your plan will cover Descovy.

If you’re not sure if you’ll need to get prior authorization for Descovy, contact your insurance company.

To learn more about the cost of Descovy, see this detailed article.

Financial and insurance assistance

If you need financial support to pay for Descovy, or if you need help understanding your insurance coverage, help is available.

Gilead Sciences, Inc., the manufacturer of Descovy, offers a program called Gilead Advancing Access. For more information and to find out if you’re eligible for support, call 800-226-2056 or visit the program website.

Save on your Descovy prescription

Save on Descovy without insurance.

Enter your information:

Location

47201

Dosage

200/25mg descovy (30 Tablets)

Save money without using insurance

Simply show the Optum Perks coupon at your preferred pharmacy or order online and instantly save up to 80% without using insurance. The coupon doesn't expire, so be sure to save it for refills.

Find your pharmacy
advertisement
SEE MORE RESULTS

Retail price refers to the manufacturer’s published list price and is up to date as of 3/2023. Retail and discounted prices are U.S.-only and can vary based on region and pharmacy. We cannot guarantee that the discounted price listed here will exactly match the price at your pharmacy. Please contact your pharmacy for the exact price.

Optum Perks and Healthline are subsidiaries of RVO Health.

Pricing source:Perks.optum.com

optum-logo

Was this helpful?

There’s no known interaction between Descovy and alcohol.

Treatment guidelines recommend that people with HIV and people at risk for HIV who drink alcohol limit their intake to moderate amounts. (This is considered one drink per day for females* or two drinks per day for males.*)

The guidelines state that drinking in moderation is thought to decrease your chances of engaging in risky behavior, such as having sex without using a condom or another barrier method. Always using a barrier method can lower your risk of transmitting HIV to someone else or contracting HIV yourself if you don’t have it.

If you drink alcohol, limiting the amount you drink can also help your immune system continue to keep HIV at low levels in your blood.

If you drink alcohol, talk with your doctor about how much alcohol is safe for you while taking Descovy.

* Sex and gender exist on spectrums. Use of the terms “female” and “male” in this article refers to sex assigned at birth.

Descovy is available only as a brand-name medication. It’s not currently available in generic form.

A generic drug is an exact copy of a brand-name medication. Generics tend to cost less than brand-name drugs.

Descovy contains two active drugs: emtricitabine and tenofovir alafenamide.

Descovy can interact with several other medications. It can also interact with certain supplements.

Different interactions can cause different effects. For instance, some interactions can interfere with how well a drug works. Other interactions can increase side effects or make them more severe.

For more information about Descovy and interactions, see this in-depth article.

Descovy and other medications

Below is a list of medications that can interact with Descovy. This list does not contain all drugs that may interact with Descovy.

Before taking Descovy, talk with your doctor and pharmacist. Tell them about all prescription, over-the-counter, and other drugs you take. Also tell them about any vitamins, herbs, and supplements you use. Sharing this information can help you avoid potential interactions.

If you have questions about drug interactions that may affect you, ask your doctor or pharmacist.

Descovy and certain seizure drugs

Taking Descovy with certain seizure drugs can lower the level of tenofovir alafenamide in your body. (Tenofovir alafenamide is one of the active drugs in Descovy.) Reduced levels of this drug can make Descovy less effective for you.

Examples of seizure drugs that can cause this interaction include:

  • carbamazepine (Carbatrol, Epitol, Tegretol)
  • oxcarbazepine (Trileptal)
  • phenobarbital
  • phenytoin (Dilantin, Phenytek)

If you need to take a seizure medication with Descovy, your doctor may prescribe a seizure drug other than the ones listed above.

Descovy and certain antibiotics or antivirals

Taking Descovy with certain antibiotics is not recommended. This is because these antibiotics can decrease the level of tenofovir alafenamide (one of the active drugs in Descovy) in your body.

Antibiotics that are not recommended to be taken with Descovy include:

  • rifabutin (Mycobutin)
  • rifampin (Rimactane)
  • rifapentine (Priftin)

If you need to take one of these antibiotics with Descovy, your doctor may recommend either a different antibiotic or a different HIV drug.

Other antibiotics or antivirals may cause Descovy levels to increase to unsafe amounts and may cause kidney damage. This is because certain antibiotics and antivirals prevent your kidneys from passing Descovy in your urine. Examples of these drugs include:

  • gentamicin (Gentak)
  • valacyclovir (Valtrex)
  • valganciclovir (Valcyte)
  • acyclovir (Zovirax)
  • ganciclovir (Zirgan)

If you need to take one of these antibiotics or antivirals while taking Descovy, your doctor may monitor your kidney function more closely than usual. They may also recommend a different treatment option for one of your conditions.

Descovy and tipranavir and ritonavir

Taking Descovy with both tipranavir (Aptivus) and ritonavir (Norvir), another combination of HIV drugs, can decrease levels of tenofovir alafenamide in your body. (Tenofovir alafenamide is one of the active drugs in Descovy.) This can make Descovy less effective for you. Taking Descovy with these drugs is not recommended.

Descovy and herbs and supplements

Taking Descovy with the herbal supplement St. John’s wort is not recommended. St. John’s wort can decrease levels of tenofovir alafenamide (one of the active drugs in Descovy) in your body. This can make Descovy less effective for you.

Check with your doctor or pharmacist before using any herbs or supplements while taking Descovy.

It’s unknown if Descovy is safe to take during pregnancy. In animal studies, there were no harmful effects to the developing fetus seen when the pregnant animal received either of the active drugs in Descovy. However, animal studies don’t always predict what will happen in humans.

There is a pregnancy registry called the Antiretroviral Pregnancy Registry that collects information about Descovy use during pregnancy. (All drugs used to prevent or treat HIV are called antiretrovirals.)

This pregnancy registry was created to help healthcare professionals determine how safe antiretroviral drugs are for use during pregnancy.

If you’ve taken Descovy during pregnancy, you’re encouraged to enroll in the registry by visiting the website or by calling 800-258-4263. You can also talk with your doctor about enrolling.

Guidelines for pregnancy and HIV

Treatment guidelines recommend that all pregnant people with HIV in the United States receive HIV treatment. This recommendation is made to protect the health of both the pregnant person and the fetus.

If you’re pregnant and have HIV, talk with your doctor about your treatment options.

It’s unknown if Descovy is safe to take during pregnancy. If you’re sexually active and you or your partner can become pregnant, talk with your doctor about your birth control needs while you’re using Descovy.

You should not breastfeed while taking Descovy if you have HIV.

Emtricitabine, one of the active drugs in Descovy, passes into human breast milk. It’s not known if tenofovir alafenamide, the other active drug in Descovy, also does. You should not breastfeed while taking Descovy because of the risk of side effects and possible development of HIV resistance (the virus is no longer sensitive to the drug) in a child who’s breastfed.

Additionally, the Centers for Disease Control and Prevention (CDC) recommends that people in the United States with HIV do not breastfeed their children. The CDC makes this recommendation to prevent the transmission of HIV to a breastfed child.

You should take Descovy according to your doctor or another healthcare professional’s instructions.

When to take

Descovy should be taken once a day, at roughly the same time each day.

If you’re taking Descovy for HIV pre-exposure prophylaxis (PrEP), you should take it every day, not just when you think you may be exposed to HIV.

To help make sure you don’t miss a dose, try setting a reminder on your phone. A medication timer may be useful, too.

Taking Descovy with food

Descovy can be taken with or without food.

Can Descovy be crushed, split, or chewed?

The manufacturer of Descovy hasn’t provided information about whether it’s safe to crush, split, or chew Descovy tablets. If you have trouble swallowing Descovy tablets, talk with your pharmacist or doctor. They can recommend ways to help you take your medication.

Descovy is approved by the Food and Drug Administration (FDA) to treat HIV in adults and certain children. It’s also approved for use as HIV pre-exposure prophylaxis (PrEP) in certain adults and adolescents.* HIV PrEP is used to prevent someone from getting HIV.

* Adolescents describes children ages 12 years and older.

What HIV does in your body

HIV is a virus that’s transmitted through blood and other bodily fluids. Once a person contracts HIV, the virus will attack certain cells in their immune system. Your immune system is your body’s natural defense against infection and disease.

HIV targets immune system cells called CD4 cells (also called T cells). CD4 cells are white blood cells that help coordinate your immune system’s response to infection. If HIV is not treated, your CD4 cell count will decrease. This reduces your immune system’s ability to fight off infection.

Eventually, your CD4 cell count can decrease to dangerously low levels, putting you at risk for potentially fatal diseases (called opportunistic infections). This is typically when a person is diagnosed with stage 3 HIV, the most severe stage of HIV.

However, treatment can reduce the amount of HIV in your blood to very low or undetectable levels. If your HIV levels remain low enough, you can live as long as somebody without HIV, with little to no risk of transmitting HIV to someone else.

How Descovy fights HIV

Descovy contains two drugs that are nucleoside reverse transcriptase inhibitors (NRTIs). These drugs prevent HIV from multiplying (making more virus). They do this by blocking an enzyme (type of protein) that the virus needs in order to copy its genetic material.

Because the virus can’t multiply, it can’t grow and spread. As a result, your HIV levels will decrease, and your CD4 cell counts will increase. This allows your immune system to fight off infection more effectively.

If you’re taking Descovy to prevent HIV, the drug works by stopping the virus from even starting to attack your immune system.

How long does it take to work?

Descovy begins working in your body within hours after you take a dose. If you’re taking Descovy for HIV pre-exposure prophylaxis (PrEP), this helps prevent HIV very soon after you start taking it. Although Descovy may begin working soon after it’s taken for PrEP, it’s recommended that you take the drug for at least 7 days before maximum prevention will occur.

If you’re taking Descovy to treat HIV, it may take several weeks or months before your HIV levels decrease and your CD4 cell counts return to your usual levels.

Here are answers to some frequently asked questions about Descovy.

If I have kidney problems, can I take Descovy?

Possibly. If you have mild or moderate kidney problems, you can take Descovy, but your doctor will likely monitor your kidney function more closely than usual. If you have severe kidney problems, you may not be able to take Descovy. Talk with your doctor about your kidney health to find out if Descovy is safe for you.

Does Descovy cure HIV?

No, and in fact, there is currently no true cure for HIV. Certain medications can suppress (lower) your HIV blood levels to undetectable amounts, but it’s still not known if this means the virus has been completely eliminated.

Keep taking Descovy for as long as your doctor prescribes it, even if your HIV levels are suppressed.

If I’m using Descovy for PrEP, what else can I do to help protect against HIV?

Most importantly, you should remember to take Descovy every single day. Missing doses raises your risk for contracting HIV.

You can also help protect yourself by using barrier methods (such as condoms) every time you engage in sexual activity. Use water-based or silicone-based lubricants with condoms to help prevent them from slipping or breaking.

Visit the Centers for Disease Control and Prevention’s Let’s Stop HIV Together website to learn about how you can get tested for HIV, prevent HIV, and treat HIV.

Can Descovy be used for PrEP by cisgender women?

No, Descovy is not approved by the Food and Drug Administration (FDA) for use as HIV pre-exposure prophylaxis (PrEP) by cisgender women.

Cisgender women are those who identify with the gender identity they were assigned at birth. In other words, cisgender women are people who were identified by healthcare professionals as being female* at birth.

This lack of approval is because Descovy hasn’t been tested for PrEP effectiveness in females who are at risk for HIV through vaginal intercourse.

It’s unknown if Descovy will protect you from HIV If you’re a person who can contract HIV through vaginal sex. Talk with your doctor about your HIV risk. They can recommend the most effective prevention options for you.

* Sex and gender exist on spectrums. Use of the term “female” in this article refers to sex assigned at birth.

This drug comes with several precautions.

FDA warnings

This drug has boxed warnings about the following risks. A boxed warning is the most serious warning from the Food and Drug Administration (FDA). It alerts doctors and patients about drug effects that may be dangerous.

  • Risk of worsening of hepatitis B: There have been reports of severe worsening of hepatitis B in people who have contracted the hepatitis B virus. This has happened after stopping treatment with emtricitabine, tenofovir disoproxil fumarate, or both. It may also occur with Descovy. If you have hepatitis B, your doctor will monitor your liver function for at least several months after you stop taking Descovy or other medications containing emtricitabine, tenofovir disoproxil fumarate, or both. They will recommend treatment for hepatitis B if needed.
  • Risk of resistance to Descovy treatment: Descovy should only be taken for pre-exposure prophylaxis (PrEP) in people who are confirmed to be HIV-negative. If you take Descovy for PrEP and you have HIV, you can develop resistance to the drug. Resistance to Descovy is when HIV is no longer sensitive to the drug. This makes Descovy less effective or no longer effective for you. Your doctor will test you for HIV before you start Descovy and every 3 months while you take Descovy. If you have HIV, they will recommend a different treatment for you.

Other precautions

Before taking Descovy, talk with your doctor about your health history. Descovy may not be right for you if you have certain medical conditions or other factors affecting your health. These include:

  • Kidney problems: Descovy has caused new or worsening kidney problems in some people. Talk with your doctor about any kidney problems you may have. They will determine whether Descovy is safe for you.
  • Liver problems: The active drugs in Descovy have caused severe liver problems in some people. Some of these people have died. Talk with your doctor about any liver problems you have. (This includes hepatitis B; see the FDA warning above.) They will determine whether Descovy is safe for you.
  • Pregnancy: It’s unknown if Descovy is safe to take during pregnancy. For more information, see the “Descovy and pregnancy” section above.
  • Breastfeeding: You should not breastfeed while taking Descovy for HIV. For more information, see the “Descovy and breastfeeding” section above.

Note: For more information about the potential negative effects of Descovy, see the “Descovy side effects” section above.

Do not use more Descovy than your doctor recommends.

If you think you’ve taken too much of this drug, call your doctor. You can also call America’s Poison Centers at 800-222-1222 or use its online tool. But if your symptoms are severe, call 911 or go to the nearest emergency room right away.

When you get Descovy from the pharmacy, the pharmacist will add an expiration date to the label on the bottle. This date is typically 1 year from the date they dispensed the medication.

The expiration date helps guarantee that the medication is effective during this time. The current stance of the Food and Drug Administration (FDA) is to avoid using expired medications. If you have unused medication that has gone past the expiration date, ask your pharmacist how to correctly dispose of it.

Storage

How long a medication remains good can depend on many factors, including how and where you store the medication.

Descovy tablets should be stored at room temperature (68°F to 77°F/20°C to 25°C) in a tightly sealed container. Avoid storing this medication in areas where it could get damp or wet, such as bathrooms.

Disposal

If you no longer need to take Descovy and have leftover medication, it’s important to dispose of it safely. This helps prevent others, including children and pets, from taking the drug by accident. It also helps keep the drug from harming the environment.

The FDA website provides several useful tips on medication disposal. You can also ask your pharmacist for information on how to dispose of your medication.

Disclaimer: Medical News Today has made every effort to make certain that all information is factually correct, comprehensive, and up to date. However, this article should not be used as a substitute for the knowledge and expertise of a licensed healthcare professional. You should always consult your doctor or another healthcare professional before taking any medication. The drug information contained herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses.

Descovy Images